U.S. Country Head, President of Novartis Corporation and President of Novartis Pharmaceuticals Corporation, Christi Shaw has oversight responsibility for 27,000 associates over six divisions, for whom “More Moments for More Memories” isn’t just a mantra – it’s a mission.

Through the lens of innovation, integrity and inclusion, she leads the US General Medicines business and Novartis Corporation operations, including U.S. site management, Public Affairs and Government Relations, as well as the overall management of US corporate reputation and social responsibility. Christi maintains an unwavering commitment to address the evolving needs of patients in collaboration with health care professionals, advocacy groups, payers and policy makers.

Joining Novartis in July 2010 as Head of North America Oncology, Christi oversaw all operations including medical, commercial and staff functions for the U.S. and Canada. During her tenure, despite significant patent losses, the North America Oncology business achieved unprecedented positive expansion; successfully launching two new chemical entities and six new indications, contributing to the strong growth of strategic brands. These significant achievements won her the 2012 Chairman’s Award for Business Excellence.

Her Oncology legacy also includes the groundbreaking “Signature” program, which is revolutionizing clinical trial recruitment by bringing the protocol to the patient versus the cancer patient to the protocol; speeding drug to patient from an average of six months to three-five weeks.